Nasal obstruction
Drug research and approvals for nasal obstruction: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 17 studies of nasal obstruction are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 17
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Pharyngeal Mucosal Conditioning to Prevent Postoperative Sore Throat in Septoplasty Patients With Severe Nasal…NCT07870252 · Not applicable · Mansoura University · starts Oct 15, 2026
- Fixed-dose Combination of 1000 mg Dipyrone Monohydrate + 60 mg Caffeine + 4 mg Chlorpheniramine Maleate in Improving…NCT07626437 · Phase 3 · Brainfarma Industria Química e Farmacêutica S/A · starts May 8, 2026
- Measuring Nasal Airway Changes After VivAer Treatment Using AI AnalysisNCT07574918 · Not applicable · Aerin Medical · starts Nov 1, 2026
- Patient-Reported Outcomes and Complications After Structural Rhinoplasty Using Septal Extension GraftsNCT07531810 · Not reported · Cumhuriyet University Hospital · starts Apr 1, 2026
- Evaluation of the Reliability of AAR as an Independent Tool for Surgical Indication in Nasal ObstructionNCT07379775 · Not reported · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · starts Jan 27, 2026
- Aesthetic and Functional Self-Assessment Following Rhinoseptoplasty in Patients With Unilateral Cleft Lip and PalateNCT07048418 · Not reported · University Hospital, Montpellier · starts Jul 9, 2025
- Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate…NCT07025304 · Not applicable · Smith & Nephew, Inc. · starts Jul 2, 2025
- Preventing Hypoxia in Sedated TAVI: SuperNO₂VA vs. Conventional OxygenNCT07006064 · Not applicable · Ankara Bilkent Sehir Hastanesi · starts May 15, 2025
- Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in…NCT06892704 · Not reported · Northwestern University · starts May 1, 2025
Approved 24 of 39
- Triamcinolone acetonideGlucocorticoid receptor agonist
- OxymetazolineAdrenergic receptor alpha agonist
- DesmopressinVasopressin receptor agonist
- PhenylpropanolamineAlpha-1a adrenergic receptor agonist
- EphedrineAdrenergic receptor agonist
- BudesonideGlucocorticoid receptor agonist
- IpratropiumMuscarinic acetylcholine receptor M3 antagonist
- ChlorpheniramineHistamine H1 receptor antagonist
- AzelastineHistamine H1 receptor antagonist
- BrompheniramineHistamine H1 receptor antagonist
- CetirizineHistamine H1 receptor antagonist
- OlopatadineHistamine H1 receptor antagonist
- LevocabastineHistamine H1 receptor antagonist
- TriprolidineHistamine H1 receptor antagonist
- DiphenhydramineHistamine H1 receptor antagonist
- DextromethorphanSigma opioid receptor agonist
- MupirocinIsoleucyl-tRNA synthetase inhibitor
- FlunisolideGlucocorticoid receptor agonist
- Beclomethasone dipropionateGlucocorticoid receptor agonist
- TriamcinoloneGlucocorticoid receptor agonist
- Fluticasone furoateGlucocorticoid receptor agonist
- Mometasone furoateGlucocorticoid receptor agonist
- DexamethasoneGlucocorticoid receptor agonist
- CiclesonideGlucocorticoid receptor agonist
Phase 3 2
- CephalexinBacterial penicillin-binding protein inhibitor
- Framycetin
Phase 2 11
Phase 1 or earlier 1
- CholecalciferolVitamin D receptor agonist
How its trials ended
81 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 14 whose ending is known, 21% met their primary endpoint, 14% missed it and 64% stopped early.
- Completed, result not reported3341%
- Ongoing2328%
- Status unknown1114%
- Stopped: other or unclear810%
- Met its primary endpoint34%
- Missed its primary endpoint22%
- Stopped: enrollment or feasibility11%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA